查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386590

即时 PCR 和数数位PCR 的全球市场：趋势、预测和竞争分析（截至 2030 年）

Real-Time PCR and Digital PCR Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

实时PCR/数位PCR的趋势和预测

预计2024年至2030年，全球即时PCR/数位PCR市场规模将以7.2%的年复合成长率成长，到2030年将达到约128亿美元。该市场的主要驱动因素是感染疾病的上升、PCR在生物标记发现中的使用不断增加以及对分子检测的日益偏好。全球即时 PCR 和数数位PCR 市场的未来前景广阔，医院和诊断中心、实验室和学术机构、製药和生物技术、临床研究机构和法医学实验室市场都充满机会。

即时 PCR/数位PCR 市场洞察

Lucintel 预测临床将在预测期内经历最高的成长。

由于慢性病的高盛行率、新型尖端基因组产品的使用增加以及该地区主要参与者的存在，北美仍将是最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业有何影响？

目录

第1章执行摘要

第2章全球即时PCR/数位PCR市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势与预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球即时PCR/数位PCR市场趋势（2018-2023）与预测（2024-2030）
  • 全球即时 PCR/数位PCR 市场：按产品类型
    • 试剂/消耗品
    • 装置
    • 软体
  • 全球即时 PCR/数位PCR 市场：依技术分类
    • 定量PCR
    • 数位PCR
  • 全球即时 PCR/数位PCR 市场：按应用分类
    • 临床
    • 研究
    • 法医学
    • 其他的
  • 全球实时 PCR/数位PCR 市场：按最终用途
    • 医院/诊断中心
    • 实验室/学术机构
    • 製药/生物技术
    • 临床研究组织
    • 法医学研究所
    • 其他的

第4章市场趋势与预测分析：按地区（2018-2030）

  • 全球即时 PCR/数位PCR 市场：按地区
  • 北美实时PCR/数位PCR市场
  • 欧洲实时PCR/数位PCR市场
  • 亚太实时PCR/数位PCR市场
  • 其他地区即时PCR/数位PCR市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按产品类型分類的全球即时 PCR/数位PCR 市场成长机会
    • 全球即时 PCR 和数数位PCR 市场的技术成长机会
    • 全球即时 PCR 和数数位PCR 市场的成长机会（按应用）
    • 按最终用途分類的全球即时 PCR 和数数位PCR 市场的成长机会
    • 按地区分類的全球即时 PCR 和数数位PCR 市场的成长机会
  • 全球实时PCR/数位PCR市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球即时PCR和数数位PCR市场的产能
    • 全球即时PCR和数数位PCR市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • F. Hoffmann La Roche
  • Takara Bio
  • Becton and Dickinson
  • Agilent Technologies
  • Merck KGaA
  • Qiagen
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Danaher
  • Bio Rad Laboratories
简介目录

Real-Time PCR and Digital PCR Trends and Forecast

The future of the global real-time PCR and digital PCR market looks promising with opportunities in the hospital and diagnostic center, research laboratory and academic institute, pharmaceutical and biotechnology, clinical research organization, and forensic laboratory markets. The global real-time PCR and digital PCR market is expected to reach an estimated $12.8 billion by 2030 with a CAGR of 7.2% from 2024 to 2030. The major drivers for this market are rising prevalence of infectious diseases, growing usage of PCR in biomarker discovery, and expanding preference for molecular testing.

A more than 150-page report is developed to help in your business decisions.

Real-Time PCR and Digital PCR by Segment

The study includes a forecast for the global real-time PCR and digital PCR by product type, technology, application, end use, and region.

Real-Time PCR and Digital PCR Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Reagents and Consumables
  • Instruments
  • Software

Real-Time PCR and Digital PCR Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Quantitative PCR
  • Digital PCR

Real-Time PCR and Digital PCR Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Clinical
  • Research
  • Forensic
  • Others

Real-Time PCR and Digital PCR Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals and Diagnostic Centers
  • Research Laboratories and Academic Institutes
  • Pharmaceutical and Biotechnology
  • Clinical Research Organizations
  • Forensic Laboratories
  • Others

Real-Time PCR and Digital PCR Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Real-Time PCR and Digital PCR Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies real-time PCR and digital PCR companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the real-time PCR and digital PCR companies profiled in this report include-

  • F. Hoffmann La Roche
  • Takara Bio
  • Becton and Dickinson
  • Agilent Technologies
  • Merck KGaA
  • Qiagen
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Danaher
  • Bio Rad Laboratories

Real-Time PCR and Digital PCR Market Insights

Lucintel forecasts that clinical is expected to witness highest growth over the forecast period.

North America will remain the largest region due to high prevalence of chronic diseases, increasing use of novel and cutting-edge genomic analysis products, and presence of key players in the region.

Features of the Global Real-Time PCR and Digital PCR Market

Market Size Estimates: Real-time PCR and digital PCR market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Real-time PCR and digital PCR market size by various segments, such as by product type, technology, application, end use, and region in terms of ($B).

Regional Analysis: Real-time PCR and digital PCR market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the real-time PCR and digital PCR market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the real-time PCR and digital PCR market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the real-time PCR and digital PCR market size?

Answer: The global real-time PCR and digital PCR market is expected to reach an estimated $12.8 billion by 2030.

Q.2 What is the growth forecast for real-time PCR and digital PCR market?

Answer: The global real-time PCR and digital PCR market is expected to grow with a CAGR of 7.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the real-time PCR and digital PCR market?

Answer: The major drivers for this market are rising prevalence of infectious diseases, growing usage of PCR in biomarker discovery, and expanding preference for molecular testing.

Q4. What are the major segments for real-time PCR and digital PCR market?

Answer: The future of the real-time PCR and digital PCR market looks promising with opportunities in the hospital and diagnostic center, research laboratory and academic institute, pharmaceutical and biotechnology, clinical research organization, and forensic laboratory markets.

Q5. Who are the key real-time PCR and digital PCR market companies?

Answer: Some of the key real-time PCR and digital PCR companies are as follows:

  • F. Hoffmann La Roche
  • Takara Bio
  • Becton and Dickinson
  • Agilent Technologies
  • Merck KGaA
  • Qiagen
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Danaher
  • Bio Rad Laboratories

Q6. Which real-time PCR and digital PCR market segment will be the largest in future?

Answer: Lucintel forecasts that clinical is expected to witness highest growth over the forecast period.

Q7. In real-time PCR and digital PCR market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to high prevalence of chronic diseases, increasing use of novel and cutting-edge genomic analysis products, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the real-time PCR and digital PCR market by product type (reagents and consumables, instruments, and software), technology (quantitative PCR and digital PCR), application (clinical, research, forensic, and others), end use (hospitals and diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology, clinical research organizations, forensic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Real-Time PCR and Digital PCR Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Real-Time PCR and Digital PCR Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Real-Time PCR and Digital PCR Market by Product Type
    • 3.3.1: Reagents and Consumables
    • 3.3.2: Instruments
    • 3.3.3: Software
  • 3.4: Global Real-Time PCR and Digital PCR Market by Technology
    • 3.4.1: Quantitative PCR
    • 3.4.2: Digital PCR
  • 3.5: Global Real-Time PCR and Digital PCR Market by Application
    • 3.5.1: Clinical
    • 3.5.2: Research
    • 3.5.3: Forensic
    • 3.5.4: Others
  • 3.6: Global Real-Time PCR and Digital PCR Market by End Use
    • 3.6.1: Hospitals and Diagnostic Centers
    • 3.6.2: Research Laboratories and Academic Institutes
    • 3.6.3: Pharmaceutical and Biotechnology
    • 3.6.4: Clinical Research Organizations
    • 3.6.5: Forensic Laboratories
    • 3.6.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Real-Time PCR and Digital PCR Market by Region
  • 4.2: North American Real-Time PCR and Digital PCR Market
    • 4.2.1: North American Real-Time PCR and Digital PCR Market by Application: Clinical, Research, Forensic, and Others
    • 4.2.2: North American Real-Time PCR and Digital PCR Market by End Use: Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology, Clinical Research Organizations, Forensic Laboratories, and Others
  • 4.3: European Real-Time PCR and Digital PCR Market
    • 4.3.1: European Real-Time PCR and Digital PCR Market by Application: Clinical, Research, Forensic, and Others
    • 4.3.2: European Real-Time PCR and Digital PCR Market by End Use: Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology, Clinical Research Organizations, Forensic Laboratories, and Others
  • 4.4: APAC Real-Time PCR and Digital PCR Market
    • 4.4.1: APAC Real-Time PCR and Digital PCR Market by Application: Clinical, Research, Forensic, and Others
    • 4.4.2: APAC Real-Time PCR and Digital PCR Market by End Use: Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology, Clinical Research Organizations, Forensic Laboratories, and Others
  • 4.5: ROW Real-Time PCR and Digital PCR Market
    • 4.5.1: ROW Real-Time PCR and Digital PCR Market by Application: Clinical, Research, Forensic, and Others
    • 4.5.2: ROW Real-Time PCR and Digital PCR Market by End Use: Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology, Clinical Research Organizations, Forensic Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Real-Time PCR and Digital PCR Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Real-Time PCR and Digital PCR Market by Technology
    • 6.1.3: Growth Opportunities for the Global Real-Time PCR and Digital PCR Market by Application
    • 6.1.4: Growth Opportunities for the Global Real-Time PCR and Digital PCR Market by End Use
    • 6.1.5: Growth Opportunities for the Global Real-Time PCR and Digital PCR Market by Region
  • 6.2: Emerging Trends in the Global Real-Time PCR and Digital PCR Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Real-Time PCR and Digital PCR Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Real-Time PCR and Digital PCR Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: F. Hoffmann La Roche
  • 7.2: Takara Bio
  • 7.3: Becton and Dickinson
  • 7.4: Agilent Technologies
  • 7.5: Merck KGaA
  • 7.6: Qiagen
  • 7.7: Abbott Laboratories
  • 7.8: Thermo Fisher Scientific
  • 7.9: Danaher
  • 7.10: Bio Rad Laboratories